Zhao, Xihai
Li, Rui
Hippe, Daniel S
Hatsukami, Thomas S
Yuan, Chun
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Chinese Atherosclerosis Risk Evaluation (CARE II) study: a novel cross-sectional, multicentre study of the prevalence of high-risk atherosclerotic carotid plaque in Chinese patients with ischaemic cerebrovascular events—design and rationale
https://doi.org/10.1136/svn-2016-000053
Comparison of carotid atherosclerotic plaques between subjects in Northern and Southern China: a Chinese atherosclerosis risk evaluation study (Results)
https://doi.org/10.1136/svn-2019-000288
Association between coexisting intracranial artery and extracranial carotid artery atherosclerotic diseases and ipsilateral cerebral infarction: a Chinese Atherosclerosis Risk Evaluation (CARE-II) study
https://doi.org/10.1136/svn-2020-000538
Detection of Advanced Lesions of Atherosclerosis in Carotid Arteries Using 3-Dimensional Motion-Sensitized Driven-Equilibrium Prepared Rapid Gradient Echo (3D-MERGE) Magnetic Resonance Imaging as a Screening Tool
https://doi.org/10.1161/strokeaha.120.032505
Differences in left and right carotid plaque vulnerability in patients with bilateral carotid plaques: a CARE-II study
https://doi.org/10.1136/svn-2022-001937
Funding for this research was provided by:
National Natural Science Foundation of China (61271132, 81271536)